The murine pan T cell marker CD96 is an adhesion receptor for CD155 and nectin-1 - PubMed (original) (raw)

. 2007 Dec 28;364(4):959-65.

doi: 10.1016/j.bbrc.2007.10.102. Epub 2007 Oct 29.

Affiliations

• PMID: 17971293
• DOI: 10.1016/j.bbrc.2007.10.102

The murine pan T cell marker CD96 is an adhesion receptor for CD155 and nectin-1

S Seth et al. Biochem Biophys Res Commun. 2007.

Abstract

The CD155 ligand CD96 is an immunoglobulin-like protein tentatively allocated to the repertoire of human NK receptors. We report here that the CD96/CD155-interaction is preserved between man and mouse although both receptors are only moderately conserved in amino acid sequence. Moreover, murine CD96 (mCD96) binds to nectin-1, a receptor related to CD155. Applying newly generated monoclonal antibodies specifically recognizing mCD96, an expression profile is revealed resembling closely that of human CD96 (hCD96) on cells of hematopoietic origin. A panel of anti-mCD96 but also recently established anti-mCD155 antibodies effectively prevents formation of CD96/CD155-complexes. This was exploited to demonstrate that the only available receptor for mCD96 present on thymocytes is mCD155. Moreover, T cell adhesion to insect cells expressing mCD155 is blocked by these antibodies depending on the T cell subtype. These results suggest a function of the CD96/CD155-adhesion system in T cell biology.

PubMed Disclaimer

Similar articles

• The adhesion receptor CD155 determines the magnitude of humoral immune responses against orally ingested antigens.
  Maier MK, Seth S, Czeloth N, Qiu Q, Ravens I, Kremmer E, Ebel M, Müller W, Pabst O, Förster R, Bernhardt G. Maier MK, et al. Eur J Immunol. 2007 Aug;37(8):2214-25. doi: 10.1002/eji.200737072. Eur J Immunol. 2007. PMID: 17621371
• Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule.
  Bottino C, Castriconi R, Pende D, Rivera P, Nanni M, Carnemolla B, Cantoni C, Grassi J, Marcenaro S, Reymond N, Vitale M, Moretta L, Lopez M, Moretta A. Bottino C, et al. J Exp Med. 2003 Aug 18;198(4):557-67. doi: 10.1084/jem.20030788. Epub 2003 Aug 11. J Exp Med. 2003. PMID: 12913096 Free PMC article.
• CD96 interaction with CD155 via its first Ig-like domain is modulated by alternative splicing or mutations in distal Ig-like domains.
  Meyer D, Seth S, Albrecht J, Maier MK, du Pasquier L, Ravens I, Dreyer L, Burger R, Gramatzki M, Schwinzer R, Kremmer E, Foerster R, Bernhardt G. Meyer D, et al. J Biol Chem. 2009 Jan 23;284(4):2235-44. doi: 10.1074/jbc.M807698200. Epub 2008 Dec 4. J Biol Chem. 2009. PMID: 19056733
• The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance.
  Fuchs A, Colonna M. Fuchs A, et al. Semin Cancer Biol. 2006 Oct;16(5):359-66. doi: 10.1016/j.semcancer.2006.07.002. Epub 2006 Jul 7. Semin Cancer Biol. 2006. PMID: 16904340 Review.
• Coming of Age: CD96 Emerges as Modulator of Immune Responses.
  Georgiev H, Ravens I, Papadogianni G, Bernhardt G. Georgiev H, et al. Front Immunol. 2018 May 17;9:1072. doi: 10.3389/fimmu.2018.01072. eCollection 2018. Front Immunol. 2018. PMID: 29868026 Free PMC article. Review.

Cited by

• PVRL2 Suppresses Antitumor Immunity through PVRIG- and TIGIT-independent Pathways.
  Yang J, Wang L, Byrnes JR, Kirkemo LL, Driks H, Belair CD, Aguilar OA, Lanier LL, Wells JA, Fong L, Blelloch R. Yang J, et al. Cancer Immunol Res. 2024 May 2;12(5):575-591. doi: 10.1158/2326-6066.CIR-23-0722. Cancer Immunol Res. 2024. PMID: 38588410 Free PMC article.
• Dysregulation of DNAM-1-Mediated NK Cell Anti-Cancer Responses in the Tumor Microenvironment.
  Paolini R, Molfetta R. Paolini R, et al. Cancers (Basel). 2023 Sep 18;15(18):4616. doi: 10.3390/cancers15184616. Cancers (Basel). 2023. PMID: 37760586 Free PMC article. Review.
• Tackling of Immunorefractory Tumors by Targeting Alternative Immune Checkpoints.
  Dulal D, Boring A, Terrero D, Johnson T, Tiwari AK, Raman D. Dulal D, et al. Cancers (Basel). 2023 May 16;15(10):2774. doi: 10.3390/cancers15102774. Cancers (Basel). 2023. PMID: 37345111 Free PMC article. Review.
• Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors.
  Dutta S, Ganguly A, Chatterjee K, Spada S, Mukherjee S. Dutta S, et al. Biology (Basel). 2023 Jan 30;12(2):218. doi: 10.3390/biology12020218. Biology (Basel). 2023. PMID: 36829496 Free PMC article. Review.
• CD96 as a Potential Immune Regulator in Cancers.
  Feng S, Isayev O, Werner J, Bazhin AV. Feng S, et al. Int J Mol Sci. 2023 Jan 9;24(2):1303. doi: 10.3390/ijms24021303. Int J Mol Sci. 2023. PMID: 36674817 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations

• Molecular Biology Databases

  • GlyGen glycoinformatics resource

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal
  • SciCrunch